Citation: Fu Yuan-Hui, Liu Ya-Ru, Zheng Yan-Peng, Jiang Nan, Yue-Ying-Jiao, Li Wei, Peng Xiang-Lei, He Jin-Sheng. An RNA polymerase I-driven human respiratory syncytial virus minigenome as a tool for quantifying virus titers and screening antiviral drug[J]. Chinese Chemical Letters, ;2017, 28(1): 131-135. doi: 10.1016/j.cclet.2016.06.018 shu

An RNA polymerase I-driven human respiratory syncytial virus minigenome as a tool for quantifying virus titers and screening antiviral drug

College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China

Corresponding author: He Jin-Sheng, jshhe@bjtu.edu.cn

Received Date: 18 April 2016
Revised Date: 15 May 2016
Accepted Date: 26 May 2016
Available Online: 22 January 2016

Figures(6)

Human respiratory syncytial virus (RSV) is an important pediatric pathogen of lower respiratory tract worldwide. No vaccines and antiviral drugs are available. Herein the use of an RNA polymerase I-driven RSV minigenome for analyzing RSV replication and screening anti-RSV drugs was investigated. The RNA polymerase I (Pol I) was used to transcribe RSV minigenome from the constructed plasmid, designated pHM-RSV-Gluc, of minigenome cDNA which comprised trailer region, gene start sequence (GS), reverse complementary copy of Gaussia luciferase (Gluc) gene, gene end sequence (GE), and leader region in the direction of 5'-3' end and was flanked by promoter and terminator of Pol I. The expression of Gluc was confirmed in pHM-RSV-Gluc transfected HEp-2 cells following RSV infection and had the characteristics of dose-dependent, which provided a rapid, sensitive, and quantitative method for quantifying virus titers and screening antiviral drugs.
- Human respiratory syncytial virus,
- Gaussia luciferase,
- Minigenome,
- Antiviral drug,
- Drug-screening
1. [1]
  Rock M.T., Crowe Jr J.E.. Identification of a novel human leucocyte antigen-A^*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein[J]. Immunology, 2003,108:474-480. doi: 10.1046/j.1365-2567.2003.01619.x
2. [2]
  Costello H.M., Ray W.C., Chaiwatpongsakorn S., Peeples M.E.. Targeting RSV with vaccines and small molecule drugs[J]. Infect. Disord. Drug Targets, 2012,12:110-128. doi: 10.2174/187152612800100143
3. [3]
  Rasmussen L., Maddox C., Moore B.P., Severson W., White E.L.. A high-throughput screening strategy to overcome virus instability[J]. ASSAY Drug Dev. Technol., 2011,9:184-190. doi: 10.1089/adt.2010.0298
4. [4]
  Kwanten L., De Clerck B., Roymans D.. A fluorescence-based high-throughput antiviral compound screening assay against respiratory syncytial virus[J]. Methods Mol. Biol., 2013,1030:337-344. doi: 10.1007/978-1-62703-484-5
5. [5]
  Perrotta A.T., Been M.D.. A pseudoknot-like structure required for efficient selfcleavage of hepatitis delta virus RNA[J]. Nature, 1991,350:434-436. doi: 10.1038/350434a0
6. [6]
  Groseth A., Feldmann H., Theriault S., Mehmetoglu G., Flick R.. RNA polymerase Idriven minigenome system for Ebola viruses[J]. J. Virol., 2005,79:4425-4433. doi: 10.1128/JVI.79.7.4425-4433.2005
7. [7]
  Freiberg A., Dolores L.K., Enterlein S., Flick R.. Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus:RNA polymerase I-and T7-catalyzed generation of functional paramyxoviral RNA[J]. Virology, 2008,370:33-44. doi: 10.1016/j.virol.2007.08.008
8. [8]
  Lundin A., Bergstr T., Bendrioua L.. Two novel fusion inhibitors of human respiratory syncytial virus[J]. Antiviral Res., 2010,88:317-324. doi: 10.1016/j.antiviral.2010.10.004
9. [9]
  Lundin A., Bergstr T., Trybala E.. Screening and evaluation of anti-respiratory syncytial virus compounds in cultured cells[J]. Methods Mol. Biol., 2013,1030:345-363. doi: 10.1007/978-1-62703-484-5
10. [10]
  Arenhart S., Flores E.F., Weiblen R., Gil L.H.V.G.. Insertion and stable expression of Gaussia luciferase gene by the genome of bovine viral diarrhea virus[J]. Res. Vet. Sci., 2014,97:439-448. doi: 10.1016/j.rvsc.2014.07.007
11. [11]
  Kwanten L., Clerck B.D., Roymans D.. A fluorescence-based high-throughput antiviral compound screening assay against respiratory syncytial virus[J]. Methods Mol. Biol., 2013,1030:337-344. doi: 10.1007/978-1-62703-484-5
12. [12]
  C. Luft, J. Freeman, D. Elliott, et al., Application of Gaussia luciferase in bicistronic and non-conventional secretion reporter constructs, BMC Biochem. 15(2014) 14.
1. [1]
  Zhenxing Li , Yue Ding , Xinxin Tuo , Jinhong Hu , Taihong Zhang , Xiang Zhou , Liwei Liu , Song Yang . Structure-based drug repurposing targeting pathogenic virus superfamily 1 helicase: An integrated multi-computational screening and bioactivity identification strategy. Chinese Chemical Letters, 2025, 36(9): 110737-. doi: 10.1016/j.cclet.2024.110737
2. [2]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
3. [3]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
4. [4]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
5. [5]
  Shaoqing Du , Xinyong Liu , Xueping Hu , Peng Zhan . Targeting novel sites represents an effective strategy for combating drug resistance. Chinese Chemical Letters, 2025, 36(1): 110378-. doi: 10.1016/j.cclet.2024.110378
6. [6]
  Qijie Gong , Jian Song , Yihui Song , Kai Tang , Panpan Yang , Xiao Wang , Min Zhao , Liang Ouyang , Li Rao , Bin Yu , Peng Zhan , Saiyang Zhang , Xiaojin Zhang . New techniques and strategies in drug discovery (2020–2024 update). Chinese Chemical Letters, 2025, 36(3): 110456-. doi: 10.1016/j.cclet.2024.110456
7. [7]
  Shifang Song , Chenyu Wu , Li Zhang , Dezhi Yang , Yang Lu , Zhengzheng Zhou . Unpacking phase transitions in multi-component drug systems: A case study. Chinese Chemical Letters, 2025, 36(7): 110911-. doi: 10.1016/j.cclet.2025.110911
8. [8]
  Jing Feng , Yanhong Liu , Liming Gong , Chenfei Liu , Congcong Xiao , Liqing Chen , Mingji Jin , Zhonggao Gao , Wei Huang , Yubo Li . Recent progress on drug delivery systems of regulating intratumoral bacteria for tumor therapy. Chinese Chemical Letters, 2025, 36(11): 110907-. doi: 10.1016/j.cclet.2025.110907
9. [9]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225
10. [10]
  Yihan Zhou , Duo Gao , Yaying Wang , Li Liang , Qingyu Zhang , Wenwen Han , Jie Wang , Chunliu Zhu , Xinxin Zhang , Yong Gan . Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108967-. doi: 10.1016/j.cclet.2023.108967
11. [11]
  Xin Zhang , Junyu Chen , Xiang Pei , Linxin Yang , Liang Wang , Luona Chen , Guangmei Yang , Xibo Pei , Qianbing Wan , Jian Wang . Drug-loading ZIF-8 for modification of microporous bone scaffold to promote vascularized bone regeneration. Chinese Chemical Letters, 2024, 35(6): 108889-. doi: 10.1016/j.cclet.2023.108889
12. [12]
  Liping Zhao , Xixi Guo , Zhimeng Zhang , Xi Lu , Qingxuan Zeng , Tianyun Fan , Xintong Zhang , Fenbei Chen , Mengyi Xu , Min Yuan , Zhenjun Li , Jiandong Jiang , Jing Pang , Xuefu You , Yanxiang Wang , Danqing Song . Novel berberine derivatives as adjuvants in the battle against Acinetobacter baumannii: A promising strategy for combating multi-drug resistance. Chinese Chemical Letters, 2024, 35(10): 109506-. doi: 10.1016/j.cclet.2024.109506
13. [13]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
14. [14]
  Fukui Shen , Yuqing Zhang , Guoqing Luan , Kaixue Zhang , Zhenzhen Wang , Yunhao Luo , Yuanyuan Hou , Gang Bai . Revealing drug targets with multimodal bioorthogonal AMPD probes through visual metabolic labeling. Chinese Chemical Letters, 2024, 35(12): 109646-. doi: 10.1016/j.cclet.2024.109646
15. [15]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
16. [16]
  Jiajia Wang , XinXin Ge , Yajing Xiang , Xiaoliang Qi , Ying Li , Hangbin Xu , Erya Cai , Chaofan Zhang , Yulong Lan , Xiaojing Chen , Yizuo Shi , Zhangping Li , Jianliang Shen . An ionic liquid functionalized sericin hydrogel for drug-resistant bacteria-infected diabetic wound healing. Chinese Chemical Letters, 2025, 36(2): 109819-. doi: 10.1016/j.cclet.2024.109819
17. [17]
  Chunlei Dai , Liying Wang , Xinru You , Yi Zhao , Zhong Cao , Jun Wu . Coffee-derived self-anti-inflammatory polymer as drug nanocarrier for enhanced rheumatoid arthritis treatment. Chinese Chemical Letters, 2025, 36(3): 109869-. doi: 10.1016/j.cclet.2024.109869
18. [18]
  Xiaoyu Hou , Mingyang Liu , Hu Wu , Nan Wang , Xu Zhao , Xifeng Qin , Xiaomin Su , Hanwei Huang , Zihan Ma , Jiahao Liu , Onder Ergonul , Füsun Can , Wei Liu , Zhiqing Pang , Funan Liu . Differential releasing hydrogel loaded with oncolytic viruses and anti-CAFs drug to enhance oncology therapeutic efficacy. Chinese Chemical Letters, 2025, 36(5): 110106-. doi: 10.1016/j.cclet.2024.110106
19. [19]
  Yue Xu , Lingzhi Wang , Liu Yang , Renliang Xue , Haowen Zhu , Qifeng Liu , Xueqi Lv , Ruiping Zhang , Jun Tu , Qingce Zang , Yinghong Wang . Spatial metabolomics combined with transcriptomics to reveal heterogeneous metabolism and drug response in the heart of rats with heart failure. Chinese Chemical Letters, 2025, 36(7): 110958-. doi: 10.1016/j.cclet.2025.110958
20. [20]
  Chenshi Lin , Chao Teng , Bingbing Li , Wei He . Anti-inflammatory drug-assisted microRNA gene therapy for effectively improving pulmonary hemodynamics. Chinese Chemical Letters, 2025, 36(7): 110450-. doi: 10.1016/j.cclet.2024.110450

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(1647)
HTML views(253)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142